COMMENTARY
Stopping colon cancer BY CRAIG JOHNSON, MD, AND HARRY SARLES JR., MD In 2001,
the Texas Society for Gastroenterology and Endoscopy (TSGE) teamed up with Texas legislators, the governor, and ultimately the citizens of Texas to enact a colorectal cancer (CRC) screen- ing bill, making Texas the second state in the nation to pass this kind of legislation. Texans now have cov- ered access to colon cancer screening. Multiple states have passed similar legislation.
Colon cancer is the second leading cause of cancer death (56,000 deaths per year) and the third most common cause of cancer (147,000 new cases per year) in the United States. Colon cancer affects men and women equal- ly. CRC can be prevented, not just de- tected, with appropriate screening by colonoscopy. Based on national data, 45 percent of Americans are taking advantage of available screening. This utilization should be 100 percent. The American College of Gastro-
Colon cancer is the second leading cause of cancer death and the third most common
enterology (ACG) screening guide- lines recommend colonoscopy as the preferred CRC prevention strategy. Screening should begin at age 50 for the average risk patient. CRC inci- dence and mortality rates are highest in African-American men and wom- en. Compared with white patients, African-Americans have decreased survival. For these reasons, African-Americans should begin screening at age 45. Survival can only improve with the use of high-quality colo-
“Doctor, how can I prevent polyps?” This is one of the most commonly asked questions after a colonoscopy. The polyp-to- cancer sequence is well established, but only 30 percent of all polyps removed are from patients with a positive family history. The answer lies in the genes. This year, patients can expect to pay about $1,000 to have their genome mapped. (Most insurance plans do not cover it.) Then they will know if they have one of many polyp/cancer markers.
Other good news includes the use
of the common aspirin in doses be- tween 81 mg and the adult size (325 mg), depending upon the patient’s risk stratification. Data suggest this daily dose reduces polyp formation. It reduces the risk of recurrence in colon cancer survivors by more than 35 percent.
Other less predictable ways to de-
cause of cancer in the United States.
noscopy. Pristine bowel preparation is essential, and the 2009 ACG guidelines recommend split dosing of the preparation as the gold standard. Colonoscopy should be performed by well- trained highly skilled physicians. Colonoscopy is the only strategy that provides prevention because of adenoma removal. Other detection tests include fecal imunohistochemical tests and CT colography.
crease polyp/cancer risk include a low-fat diet and high dietary calcium. Lastly, what about alcohol? The
Wall Street Journal summarized the two faces of alcohol in a Nov. 1, 2011, article. The risk for colon cancer in- creases 52 percent in people who have more than two drinks per day. A drink is considered to be 4 to 5 ounc- es of wine, 12 ounces of beer, or 1.5
ounces of 80-proof liquor. March is designated as Colorectal Cancer Awareness Month.
TSGE recommends all physicians in Texas talk to their patients about appropriate screening for CRC. For more information, go to
www.gi.org. n
Dr. Johnson and Dr. Sarles are past presidents of the Texas Society for Gastroenterol- ogy and Endoscopy. Dr. Johnson practices in Houston. Dr. Sarles practices in Rockwall.
March 2012 TEXAS MEDICINE 55
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60